Impact of Comorbidities and Drug Interactions in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Androgen Receptor Pathway Inhibitors.

Ying Yan Zhong Angelyn Anton Owen XieNatalie TanSophie O'Haire Sam Maleki Andrisha-Jade InderjeethPhillip ParenteLavinia SpainPeter Gibbs Ben Tran

Published in: JCO oncology practice (2024)

DDIs and drug-comorbidity interactions in real-world patients receiving ARPIs for mCRPC are common and may affect outcomes. Ongoing clinician education regarding DDIs is necessary to optimize patient outcomes.

Keyphrases

healthcare
quality improvement
adverse drug
emergency department
metabolic syndrome
drug induced
weight loss